Delivery Order SPE2DE24D0013-SPE2D626F55D1

The Defense Logistics Agency Medical Supply Chain awarded a $1,840 firm fixed-price delivery order to Cepheid Inc. on December 23, 2025, with an ultimate completion date of December 31, 2025. This delivery order, designated XPRSTREPA-10, represents work to be performed at Cepheid's headquarters in Sunnyvale, California. The contract carries no set-aside designation and falls under a delivery order contract type, reflecting a transactional procurement of molecular diagnostic supplies or reagents from the vendor's existing contracting vehicle. Given Cepheid's established role as a primary federal supplier of diagnostic solutions, particularly its GeneXpert diagnostic platform and associated molecular testing capabilities, this delivery order likely involves diagnostic testing supplies or reagents supporting the Defense Logistics Agency's medical supply chain operations.

Cepheid Inc., a for-profit manufacturer of advanced molecular diagnostic systems headquartered in Sunnyvale, California, has established extensive federal contracting relationships across multiple agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and the U.S. Coast Guard. The company holds substantial indefinite delivery contracts, most notably a $32.8 million agreement with Veterans Affairs VISN 6 through September 2030 and a $6.7 million contract with VISN 17 through December 2029, both providing the framework for ongoing procurement of diagnostic reagents and test kits. Cepheid's core competencies encompass rapid molecular diagnostic testing for infectious diseases including COVID-19, influenza, tuberculosis, and resistant bacterial infections, making the company a cornerstone supplier for federal healthcare diagnostic capabilities across both military and civilian healthcare systems.